EWA
STIM icon

EverSource Wealth Advisors’s Neuronetics STIM Stock Holding History

EverSource Wealth Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$788 Buy
606
+55
+10% +$80 ﹤0.01% 4039
2026
Q1 		$799 Buy
+551
New +$873 ﹤0.01% 3932

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EverSource Wealth Advisors's STIM Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Neuronetics (STIM) stake by 10% in Q2 2026, buying an estimated $80 and bringing the position to 606 shares worth $788. The position accounts for ﹤0.01% of the portfolio, ranked #4039.

EverSource Wealth Advisors first reported a position in STIM in Q1 2026 and has held it in 2 quarters since. The position peaked at $799 in Q1 2026. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • EverSource Wealth Advisors held 606 shares of Neuronetics worth $788 as of Q2 2026.
  • EverSource Wealth Advisors bought 55 Neuronetics shares in Q2 2026, an estimated $80.
  • Neuronetics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4039 holding.
  • EverSource Wealth Advisors first reported a position in Neuronetics in Q1 2026 and has held it in 2 quarters since.
  • EverSource Wealth Advisors's Neuronetics position peaked at $799 in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.